Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
0 hedge funds and large institutions have $0 invested in Odonate Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $7.13M → $0 (-$7.13M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$5.55M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$925K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$506K |
| 4 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$91K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$58K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Boxer Capital
San Diego,
California
| – | -$5.55M | -4,207,086 | Closed |
|
|
SB
2
Samsara BioCapital
Palo Alto,
California
| – | -$925K | -700,421 | Closed |
|
|
3
Acadian Asset Management
Boston,
Massachusetts
| – | -$506K | -384,995 | Closed |
|
|
HWAM
4
Hennion & Walsh Asset Management
Parsippany,
New Jersey
| – | -$91K | -69,264 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$58K | -43,752 | Closed |
|
6
Simplex Trading
Chicago,
Illinois
| – | -$2K | -2,000 | Closed |
|
ODT Hedge Fund Activity: Q2 2022 in Review
0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q2 2022, worth a combined $0 — down 100% from $7.13M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ODT and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Boxer Capital, exiting entirely with an estimated $5.55M sold.
- 0 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q2 2022, down from 8 in Q1 2022.
- Funds reported $0 of Odonate Therapeutics, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q2 2022 and 8 closed out, a net change of -8 holders.
- The largest Odonate Therapeutics, Inc. Common Stock seller in Q2 2022 was Boxer Capital, an estimated $5.55M sold.
Based on aggregated 13F filings for Q2 2022.